Introduction

Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials of medicines and vaccines. Thimerosal is a benign preservative at the center of several vaccine/autism conspiracy theories.

"The thimerosal/autism link was debunked many years ago through both large epidemiological studies and even nonhuman primate neurodevelopment studies."

Peter Hotez, American Vaccinologist and Pediatrician

For much of the twentieth century, thimerosal quietly played a supporting role in public health. As an ethyl‑mercury–based preservative, it was introduced in the 1930s to prevent bacterial and fungal contamination in multi‑dose vaccine vials - a real and sometimes deadly threat before modern manufacturing and cold-chain systems matured. For decades, it did exactly what it was designed to do: keep vaccines safe, stable, and accessible, especially in settings where single-dose vials were impractical or unaffordable.

Its story changed in the late 1990s, not because of new scientific evidence, but because of a shift in public perception. As awareness of environmental mercury exposure grew, thimerosal became entangled in broader anxieties about toxins, childhood health, and the rapid rise in autism diagnoses. Although ethyl-mercury behaves very differently from the methyl‑mercury found in environmental exposures - clearing from the body far more quickly - the distinction was easily lost in public discourse. A precautionary review by U.S. health agencies recommended reducing or removing thimerosal from childhood vaccines, not due to demonstrated harm, but to maintain public confidence

This decision, while well‑intentioned, had unintended consequences. The removal of thimerosal was interpreted by some as evidence that it had been dangerous all along. A narrative took hold: if it was taken out, it must have been harmful. Even after large epidemiological studies across multiple countries found no link between thimerosal and autism, the myth persisted, fueled by misinformation, distrust of institutions, and the emotional weight of parents seeking explanations for complex developmental conditions.

Globally, the impact has been uneven. In high‑income countries, the shift to single‑dose vials was feasible, though more expensive. In many low‑ and middle‑income regions, thimerosal‑containing multi‑dose vials remain essential for maintaining vaccine supply, affordability, and rapid deployment during outbreaks. The World Health Organization continues to support their use, emphasizing that the scientific consensus on safety is robust.

Thimerosal’s legacy is therefore twofold. Scientifically, it stands as a reminder that risk must be evaluated through evidence, not intuition. Socially, it illustrates how fragile public trust can be—and how easily uncertainty can be amplified when communication falters. Its story underscores a central truth of modern public health: the success of vaccines depends not only on biology and manufacturing, but on the collective confidence of the communities they are meant to protect.